Individual responses can vary widely, but medical studies suggest that viscosupplementation usually takes several weeks to provide noticeable relief. The benefits typically last 4 to 6 months, though some patients experience longer-lasting improvement. Your personal response is the best indicator of how long the effects will persist. Follow-up frequency will be adjusted accordingly with your provider. On average, most patients require about two injections per year to maintain symptom control.

While any joint can potentially benefit from viscosupplementation, the knee, hip, and shoulder joints are the most extensively studied and most commonly treated. The suitability of viscosupplementation for other joints can be assessed on a case-by-case basis by your healthcare provider.

The cost of viscosupplementation is $490 per joint, which includes both the Durolane product and the ultrasound-guided injection procedure. Patients can be referred by their family doctor to Dr. Boomgaardt or may choose to self-refer.

For self-referral cases, an initial consultation fee of $200 applies, with follow-up visits at $100 each. 

While viscosupplementation is not currently covered by OHIP, many private insurance plans offer at least partial reimbursement for this treatment.
For example, Canada Life may cover up to 80% of injectable costs (to a maximum of $600 per year), and Blue Cross often provides full coverage for viscosupplementation.
You can review a list of common insurance plans and their coverage details here to help determine your eligibility.
Please note that we are unable to bill third-party insurers directly or check coverage on your behalf, but we’re happy to support you with any information you may need to assist with your claim.